Theravance Biopharma Inc. (TBPH)
NASDAQ · Healthcare
Theravance Biopharma Inc. Total Liabilities 2012–2025
Theravance Biopharma Inc. annual/quarterly total liabilities history from 2013 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Theravance Biopharma Inc. total liabilities for the quarter ending December 31, 2025 were 188.8M, a 5.73% increase year-over-year.
- Theravance Biopharma Inc. total liabilities for 2025 were 188.8M, a 5.73% increase from 2024.
- Theravance Biopharma Inc. total liabilities for 2024 were 178.6M, a 5.69% increase from 2023.
- Theravance Biopharma Inc. total liabilities for 2023 were 169.0M, a 2.06% increase from 2022.
- Theravance Biopharma Inc. total liabilities for 2022 were 165.6M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Theravance Biopharma Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $189 |
| 2024 | $179 |
| 2023 | $169 |
| 2022 | $166 |
| 2021 | $713 |
| 2020 | $773 |
| 2019 | $633 |
| 2018 | $612 |
| 2017 | $326 |
| 2016 | $289 |
| 2015 | $57 |
| 2014 | $48 |
| 2013 | $42 |
| Theravance Biopharma Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $189 |
| 2024-12-31 | $179 |
| 2023-12-31 | $169 |
| 2022-12-31 | $166 |
| 2021-12-31 | $713 |
| 2020-12-31 | $773 |
| 2019-12-31 | $633 |
| 2018-12-31 | $612 |
| 2017-12-31 | $326 |
| 2016-12-31 | $289 |
| 2015-12-31 | $57 |
| 2014-12-31 | $48 |
| 2013-12-31 | $42 |
Theravance Biopharma Inc. Total Liabilities — FAQ
Theravance Biopharma Inc. (TBPH) total liabilities over the last 14 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TBPH's total liabilities history?
The chart and table above show Theravance Biopharma Inc.'s total liabilities by year and by quarter, including the growth rate.